Thirteen countries from Asia and the Pacific plan scale-up of PrEP and HIV self-testing
BANGKOK, 31st October 2018 – Representatives from 13 countries across Asia and the Pacific gathered in Bangkok, Thailand, from 29 to 31 October to develop road maps to implement and expand pre-exposure prophylaxis (PrEP) and HIV self-testing in the region.
In discussions on building capacity for the rollout of PrEP and HIV testing innovations in Asia and the Pacific, policy-makers, health care providers, researchers and advocates from key populations discussed barriers to scale up these tools and shared lessons learned.
PrEP reduces the risk of acquiring HIV by more than 90 percent, and HIV self-testing can significantly increase the number of people who find out their status, particularly among those at highest risk and least reached by existing services. This means that adequate use of these products is set to revolutionize HIV prevention across Asia and the Pacific. In China, Indonesia, Malaysia, Pakistan and the Philippines for example, infections among men that have sex with men (MSM) continue to rise, and HIV prevalence has hit 25.8 percent in Indonesia and 21.6 percent in Malaysia. MSM could make up at least half of all new HIV infections in Asia by 2020.
“The numbers say it all. We cannot stop new HIV infections in men who have sex with men and other key populations if we stick to business as usual,” said Eamonn Murphy, UNAIDS Regional Director for Asia and the Pacific. “PrEP answers an unmet need and expands the prevention options for people at substantial risk of HIV. We need to scale up PrEP as an additional effective HIV prevention intervention.”
“HIV self-testing and PrEP are game-changing innovations for millions of people who do not know they are infected or at high risk of contracting HIV,” said Heather Ingold, HIV programme manager at Unitaid. “Together with the World Health Organization, UNAIDS and partners we must advocate for their scale-up in Asia and the Pacific.”
Most countries in the region do not have policies in place to implement PrEP or HIV self-testing at scale. However, a handful of countries are taking the lead and have included these innovative interventions into their national HIV strategies.
“WHO is pleased to join with Unitaid, UNAIDS and PSI to support the meeting on HIV self-testing and PrEP in Asia “, said Rachel Baggaley, WHO’s coordinator of HIV testing and prevention. “WHO first recommended HIV self-testing in 2016; 59 countries now have policies, but only 28 are implementing. HIV self-testing needs to become more widely available, affordable and accessible to reach the 90-90-90 targets. WHO has also recommended PrEP since 2015. If we are going to scale up PrEP, if we are going to reach levels of coverage that translate into public health impact, we need to engage and support key populations to deliver PrEP in Asia.”, she concluded.
Participants discussed roadblocks to scale-up, including lack of political commitment, investments, national guidance; as well as stigma and discrimination towards key populations. They also emphasized the need to integrate PrEP and HIV self-testing into national programs, work with the private sector, and to further involve communities to increase demand and improve service delivery.
The meeting was coordinated by Unitaid, UNAIDS, and WHO. Attendees included representatives from Ministries of Health, country and regional partners and networks working on PrEP and HIV self-testing, civil society representatives from Bangladesh, Cambodia, China, Indonesia, India, Lao PDR, Malaysia, Myanmar, Pakistan, Papua New Guinea, Philippines, Thailand and Viet Nam, WHO and UNAIDS country and regional HIV focal points and representatives from civil society including APCOM and APTN as well as other partners such as PEPFAR, CDC, FHI360 and the Global Fund for AIDS, TB and Malaria.
Andrew Hurst, Team Lead, Communications
Tel: +41 79 561 68 07, firstname.lastname@example.org
Michela Polesana, Communication Adviser, UNAIDS Regional Office for Asia and the Pacific,
Tel: +66 945 194092, email@example.com
About Unitaid and UNAIDS
Unitaid brings the power of new medical discoveries to the people who most need them and helps set the stage for the large-scale introduction of new health products by collaborating with governments and partners such as PEPFAR, the Global Fund UNAIDS and WHO. Unitaid invests in new ways to prevent, diagnose and treat HIV/AIDS, hepatitis C, tuberculosis and malaria more quickly, affordably and effectively. A growing number of our programs address more than one disease, maximizing effectiveness of health systems.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube